iBio (IBIO) Selling, General & Administrative (2010 - 2026)
iBio's Selling, General & Administrative was -$2.18 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $2.17 million a year earlier.
iBio (IBIO) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Selling, General & Administrative at iBio came in at $10.6 million, down 0.9% from FY2025.
- Selling, General & Administrative has now declined for five consecutive fiscal years, with a five-year compound annual growth rate of -13.6% (FY2021 to FY2026).
- In earlier fiscal years, Selling, General & Administrative was $10.69 million in FY2025 (-8.4%), $11.67 million in FY2024 (-38.6%), $19.02 million in FY2023 (-12.6%) and $21.75 million in FY2022 (-1.3%).
- The fiscal Q4 2026 figure marks the lowest quarterly Selling, General & Administrative in data going back to fiscal Q1 2011.
- Compared with a year earlier, Selling, General & Administrative was higher in three of the last seven quarters, with growth averaging 17.0%.
- The best year-over-year quarter for Selling, General & Administrative over five years was fiscal Q2 2026 (growth of 88.4%); the worst was fiscal Q4 2023 (a decline of 62.1%).
- Per Business Quant data, IBIO's Selling, General & Administrative in the three fiscal quarters before Q4 2026 was $5.11 million (Q3 2026), $5.17 million (Q2 2026) and $2.5 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | iBio | 116.55 Mn | 116.55 Mn | - | -2.18 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.18 Mn |
| Mar 31, 2026 | 5.11 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 2.50 Mn |
| Jun 30, 2025 | 2.17 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.80 Mn |
| Jun 30, 2024 | 2.44 Mn |
| Mar 31, 2024 | 2.72 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 3.55 Mn |
| Jun 30, 2023 | 2.61 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | 7.79 Mn |
| Sep 30, 2022 | 5.09 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Mar 31, 2022 | 5.32 Mn |
| Dec 31, 2021 | 5.37 Mn |
| Sep 30, 2021 | 4.18 Mn |
iBio Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();